PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
January 6, 2011 | ISSUE NUMBER 181 VOL 8

From the Editor
New Year Night Stalkers
What will be keeping the ‘C-suiters’ awake during 2011?

Global
Learning from Other Industries in Emerging Markets
How does pharma move beyond the traditional reliance on serving the smallest, most affluent segment of the market to seed critical mass?

Regulatory
FDA Joins PIC/S
After five years of discussions, the US Food and Drug Administration joins the Pharmaceutical Inspection Convention (PIC) and the Pharmaceutical Inspection Cooperation Scheme (PIC Scheme).

Technology
Will Cellular Doom the Paper Chase?
Practical sales and marketing applications of the latest mobile technology for healthcare professionals.


// PharmaNet Development Group, Inc., (Princeton, NJ) announced that Catherine Derasp, RN, has joined the Company as Vice President, Clinical Operations of the Company's Phase I clinics. //Alexander Wessels, previously President and CEO of DSM Food Specialties, assumed responsibility for DSM Pharmaceutical Products (Parsippany, NJ). // WorldCare Clinical, LLC (Boston, MA), an imaging CRO, announced that Dr. Xiaozhou Ma joined the organization as Associate Diirector of quantification and 3D imaging. //OmniComm Systems, Inc. (Fort Lauderdale, FL), announced the appointment of Keith Howells as Vice President of Engineering. //

Jan 11–12, 2011: The State of Clinical Development Costs
Philadelphia, PA


Jan 24–25, 2011 8th Annual Pharmaceutical Compliance Congress
Washington, DC

Feb 1–2, 2011: Pharma Market Research
Parsippany, NJ

 

 
FindPharma  
Search  

Survey
Who do you think will become the most influential healthcare stakeholders in the next few years?
Click To Vote
 
 
 
Quick Links

Dr. Reddy’s Forms Technology and Manufacturing Pact in Russia

Europe Medicines Agency Outlines Five-Year Plan

New Obesity Drug Closer to Approval


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive